BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED

Boehringer Ingelheim India Private Limited Company Profile

Boehringer Ingelheim India Private Limited is the Indian subsidiary of Boehringer Ingelheim, a leading global research-driven pharmaceutical company headquartered in Ingelheim, Germany. Established in 1885, Boehringer Ingelheim is one of the world's top pharmaceutical companies, focusing on developing, manufacturing, and marketing innovative medicines for human and animal health.

In India, Boehringer Ingelheim operates across several key therapeutic areas, including cardiovascular diseases, respiratory diseases, diabetes, oncology, and central nervous system disorders. The company is dedicated to improving the health and quality of life for patients through its portfolio of innovative products. Its activities in India encompass clinical research, product development, regulatory affairs, marketing, sales, and distribution of its global range of pharmaceutical and animal health products.

Factory or Trader:

Boehringer Ingelheim India Private Limited is primarily a pharmaceutical manufacturer and marketer. As part of a global pharmaceutical enterprise, the company is involved in the development, manufacturing (either directly or through contract manufacturing organizations under stringent quality control), and distribution of its proprietary medicines. Therefore, it is not merely a trader; it functions as a comprehensive pharmaceutical company with manufacturing capabilities and a strong focus on research, development, and marketing of its own products.

BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED produces and sells a range of pharmaceutical products for humans and animals.

Human Pharmaceuticals:

Medicines for diabetes, including Jardiance (empagliflozin) and Trajenta (linagliptin).

Cardiovascular medicines such as Pradaxa (dabigatran), Twynsta (telmisartan/amlodipine), and Micardis (telmisartan).

Respiratory medicines like Spiriva (tiotropium) and Ofev (nintedanib).

Medicines for idiopathic pulmonary fibrosis and other fibrotic diseases, including Ofev (nintedanib).

Oncology products such as Giotrif (afatinib).

Products for Central Nervous System disorders, including Sifrol (pramipexole).

Animal Health:

Pet parasiticides like NexGard (afoxolaner) and Frontline (fipronil).

Vaccines and pharmaceuticals for livestock, including products for swine, poultry, and cattle.